Medicalsystem Biotechnology Co., Ltd

Equities

300439

CNE100001Z25

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 24/06/2024 am IST			5-day change	1st Jan Change
8.92 ^CNY	-3.88%		-3.98%	-23.17%

24/06	Medicalsystem Biotechnology Secures Registration Certificates for Diagnostic Reagents	MT
03/06	Medicalsystem Biotechnology Co., Ltd Announces Cash Dividend on A Shares for 2023, Payable on 7 June 2024	CI

Medicalsystem Biotechnology Co., Ltd Announces Cash Dividend on A Shares for 2023, Payable on 7 June 2024

June 04, 2024 at 01:03 am IST

Medicalsystem Biotechnology Co. Ltd. announced final cash dividend/10 shares (tax included) of CNY 1.340000000 on A shares for the year 2023. Record date: 6 June 2024 Ex-date: 7 June 2024 and Payment date: 7 June 2024.

Latest news about Medicalsystem Biotechnology Co., Ltd

Medicalsystem Biotechnology Secures Registration Certificates for Diagnostic Reagents	24/06	MT
Medicalsystem Biotechnology Co., Ltd Announces Cash Dividend on A Shares for 2023, Payable on 7 June 2024	04/06	CI
MedicalSystem Biotechnology Gets Nod to Register Two Devices in Zhejiang, China	03/06	MT
Medicalsystem Biotechnology Co., Ltd Approves Cash Dividend for the Year 2023	28/05	CI
MedicalSystem Biotechnology Gets Registration Certificates for Two Products	22/05	MT
Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04	CI
Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	18/04	CI
MedicalSystem Biotechnology Gets Nod to Market Fibrinogen Detection Kit	22/03	MT
Medicalsystem Biotechnology Co., Ltd Announces Board Appointments	19/12	CI
Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25	CI
MedicalSystem Biotechnology Registers Thyroid Protein Detection Kit	04/23/04	MT
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	18/23/18	CI
Ningbo Ruiheyuan Biotechnology Co., Ltd. announced that it expects to receive CNY 192 million in funding from Medicalsystem Biotechnology Co., Ltd	18/23/18	CI
Medicalsystem Biotechnology Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 16 June 2023	10/23/10	CI
Medicalsystem Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2022	23/23/23	CI
MedicalSystem Biotechnology Registers Two New Medical Devices	22/23/22	MT
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Medicalsystem Biotechnology Co., Ltd. Approves Final Dividend for 2022	27/23/27	CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/23/25	CI
Chen Chaohong completed the acquisition of a 5% stake in Medicalsystem Biotechnology Co., Ltd. from Zou Bingde.	02/23/02	CI
MedicalSystem Biotechnology Registers Two New Medical Devices in China	16/23/16	MT
MedicalSystem Biotechnology Registers Two New Medical Devices	01/23/01	MT
Chen Chaohong signed the Share Transfer Agreement to acquire 5% stake in Medicalsystem Biotechnology Co., Ltd. from Zou Bingde for approximately CNY 180 million	24/22/24	CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI

Chart Medicalsystem Biotechnology Co., Ltd

Duration

Period

Chart Medicalsystem Biotechnology Co., Ltd

More charts

Company Profile

MedicalSystem Biotechnology Co., Ltd. is a China-based company engaged in the research and development, manufacture and distribution of in-vitro diagnostic products. The Companyâs in-vitro diagnostic products include in-vitro diagnostic reagent and in-vitro diagnostic instrument. In addition, the Company is also involved in the provision of third-party medical diagnosis services, as well as the production and distribution of reagent raw materials. The Company mainly operates businesses in domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

19/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
MEDICALSYSTEM BIOTECHNOLOGY CO., LTD	-23.17%	47Cr
BIOMÉRIEUX	-10.29%	1.15TCr
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-12.05%	744.51Cr
LANTHEUS HOLDINGS, INC.	+27.34%	547.22Cr
DIASORIN S.P.A.	+1.59%	548.57Cr
AUTOBIO DIAGNOSTICS CO., LTD.	-18.40%	372.04Cr
ANDON HEALTH CO., LTD.	+5.52%	253.54Cr
10X GENOMICS, INC.	-64.47%	237.98Cr
VITROLIFE AB	-8.06%	231.56Cr
MYRIAD GENETICS, INC.	+28.11%	221.93Cr

Diagnostic & Testing Substances